← Back to Search

Cervical Cancer Screen-and-Treat Strategies for Cervical Cancer (ACCESS Trial)

N/A
Recruiting
Led By Gregory Aarons, PhD
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Women living with HIV
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months after enrollment
Awards & highlights

ACCESS Trial Summary

This trial aims to increase cervical cancer screening & treatment for women living with HIV in Nigeria, improving health & life expectancy.

Who is the study for?
This trial is for women living with HIV in certain low- and middle-income countries. It aims to improve cervical cancer screening and treatment by using existing HIV care infrastructure.Check my eligibility
What is being tested?
The ACCESS study compares two approaches: 'Core' strategies versus 'Core+' enhanced strategies, to integrate cervical cancer screen-and-treat services into HIV programs, assessing effectiveness through a cluster randomized design.See study design
What are the potential side effects?
Since the interventions involve implementation strategies rather than medications, traditional side effects are not applicable. However, there may be indirect impacts on patient experience based on how services are delivered.

ACCESS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

ACCESS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months after enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months after enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Reach
Sustainment
Secondary outcome measures
CCST Effectiveness

ACCESS Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Core+ Enhanced Implementation StrategiesExperimental Treatment1 Intervention
Includes all of the Core implementation strategies and adds: 5. Community engagement using Health Beginning Initiative Model 6. Smart Cards to facilitate patient engagement
Group II: Core Implementation StrategiesActive Control2 Interventions
Core Implementation Strategies Ongoing consultation Educational meetings Strengthen referral system Prepare patients to be active participants

Find a Location

Who is running the clinical trial?

University of Nigeria NsukkaOTHER
1 Previous Clinical Trials
3,744 Total Patients Enrolled
University of California, San DiegoLead Sponsor
1,121 Previous Clinical Trials
1,518,488 Total Patients Enrolled
Gregory Aarons, PhDPrincipal InvestigatorUniversity of California, San Diego

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are geriatric individuals invited to participate in this experiment?

"As indicated by the trial's inclusion criteria, only patients aged 25 to 65 can participate. There are 72 clinical trials available for those under 18 and 569 options accessible to individuals over the age of 65."

Answered by AI

Is it possible to sign up for participation in this experiment?

"This clinical trial is seeking 2436 HIV/AIDS patients aged 25 to 65. Eligible applicants must meet this age and health criteria in order to be considered for the study."

Answered by AI

Does this investigation have any open slots for participants?

"The data hosted on clinicaltrials.gov indicates that this medical study, initially posted November 13th 2023, is not currently seeking participants. However, there are 659 other studies that are actively enrolling patients at the moment."

Answered by AI
~1624 spots leftby Aug 2026